Week In Review: China Issues Rules For Trials Of Stem Cell Treatments
September 12, 2015 at 16:00 PM EDT
Under the new rules, clinical trials must be conducted in Tier IIIa hospitals, records kept for 30 years, an ethics panel must oversee the trial, certified stem cell lines must be used, and patients must be monitored after treatment ends.
